Interobserver and intraobserver agreement in PET/CT with [18F]DCFPyL according to TNM molecular and PSMA-RADS 2.0

M Guerra-Gómez1, A Rodríguez-Pajuelo1, L Brero-Sánchez1

  • 1Departamento de Medicina Nuclear, Hospital Universitario Virgen del Rocío, Sevilla, Spain.

Abstract

Insights

This study shows that using PSMA-RADS 2.0 criteria and the miTNM system for prostate cancer PET-PSMA imaging leads to reproducible results. Observers achieved good agreement, especially when ruling out disease, supporting its clinical use.

Area of Science:

  • Nuclear Medicine
  • Radiology
  • Oncology

Background:

  • Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) is crucial for staging prostate cancer.
  • Standardized criteria are needed to improve the interpretation of PSMA PET-PSMA images.

Purpose of the Study:

  • To assess the agreement between observers with varying experience using PSMA-RADS 2.0 and miTNM systems for interpreting [18F]DCFPyL PET-PSMA in prostate cancer patients.
  • To evaluate the reproducibility of these interpretation systems.

Main Methods:

  • 114 prostate cancer patients' PET-PSMA images were independently reviewed twice by three observers.
  • Interpretations were performed using the molecular imaging TNM (miTNM) and PSMA-RADS 2.0 criteria.
  • Inter- and intraobserver agreement were analyzed using Fleiss' Kappa.

Main Results:

  • Moderate overall agreement was observed (Fleiss' Kappa = 0.53).
  • Substantial agreement was found for prostatic disease and lymphatic involvement (Kappa = 0.66 and 0.65, respectively).
  • High agreement was noted for metastatic disease (Kappa = 0.86), particularly in the M0 group (Kappa = 0.99).

Conclusions:

  • The PSMA-RADS 2.0 and miTNM systems provide a highly reproducible format for interpreting PSMA PET-PSMA images in prostate cancer.
  • High inter- and intraobserver agreement, especially in excluding disease, supports the routine clinical application of these systems.